Todos Medical Completes Acquisition of Key Assets and Intellectual Property from NLC Pharma
16 mars 2022 07h00 HE
|
Todos Medical Ltd.
- Forms new subsidiary, 3CL Pharma, focused on the development and commercialization of 3CL protease-related products including Tollovir™, Tollovid®, Tollovid Daily™ and TolloTest™ for COVID-19 - ...